๐ฐ Juniper Point News
Page 5 - Juniper Point News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Juniper Point. Real-time updates on events, politics, business and more.
December 9, 2022
SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision...
December 9, 2022
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use...
December 7, 2022
SAN DIEGO, Dec. 7, 2022 /PRNewswire/ -- Congruence Therapeutics, a biotechnology company working at the interface of computational and experimenta...
December 7, 2022
/PRNewswire/ -- Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel...
November 10, 2022
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced that the Company will participate at the...
October 5, 2022
/PRNewswire/ -- Renibus Therapeuticsยฎ ("Renibus"), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases, today...
September 29, 2022
/PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Suzanne...
September 23, 2022
SAN DIEGO, Sept. 23, 2022 -- Bionano Genomics, Inc. today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping data services with... | September 23, 2022
September 8, 2022
Jean L Golden, 81, of Pittsford, New York, passed away peacefully on Aug.13 with family by her side after obstinately thumbing her nose at cancer for nearly 11 years. Born Jean Virginia Lenhart on February 11, 1941 in Middletown, Connecticut to the...
September 8, 2022
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company harnessing the power of myeloid and innate biology to...